ACM
BMY icon

Aquatic Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Aquatic Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,016
Closed -$1.62M – 1391
2025
Q4 		$1.62M Sell
30,016
-1,029,029
-97% -$49.5M 0.05% 425
2025
Q3 		$47.8M Buy
1,059,045
+850,758
+408% +$39.7M 0.89% 12
2025
Q2 		$9.64M Buy
+208,287
New +$10.2M 0.19% 136
2024
Q4 		– Sell
-220,600
Closed -$11.4M – 1346
2024
Q3 		$11.4M Sell
220,600
-588,400
-73% -$27.6M 0.3% 93
2024
Q2 		$33.6M Buy
+809,000
New +$36.2M 1.24% 13
2024
Q1 		– Sell
-76,200
Closed -$3.91M – 1241
2023
Q4 		$3.91M Sell
76,200
-248,300
-77% -$13M 0.1% 209
2023
Q3 		$18.8M Buy
324,500
+239,900
+284% +$14.7M 0.79% 27
2023
Q2 		$5.41M Buy
84,600
+3,100
+4% +$208K 0.29% 83
2023
Q1 		$5.65M Sell
81,500
-191,300
-70% -$13.5M 0.35% 75
2022
Q4 		$19.6M Buy
+272,800
New +$20.6M 1.43% 5

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aquatic Capital Management's BMY Position: Q1 2026 in Review

Aquatic Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 30,016 shares — an estimated $1.62M sold.

Aquatic Capital Management first reported a position in BMY in Q4 2022 and held it in 10 quarters. The position peaked at $47.8M in Q3 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Aquatic Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 30,016 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.62M.
  • Aquatic Capital Management first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 10 quarters.
  • Aquatic Capital Management's Bristol-Myers Squibb position peaked at $47.8M in Q3 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.